212 related articles for article (PubMed ID: 21718201)
1. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma.
Klahn SL; Kitchell BE; Dervisis NG
J Am Vet Med Assoc; 2011 Jul; 239(1):90-6. PubMed ID: 21718201
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
Skorupski KA; Rodriguez CO; Krick EL; Clifford CA; Ward R; Kent MS
Vet Comp Oncol; 2009 Jun; 7(2):139-44. PubMed ID: 19453368
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).
Boston SE; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2006 Jun; 228(12):1905-8. PubMed ID: 16784383
[TBL] [Abstract][Full Text] [Related]
4. Prior joint disease is associated with increased risk of periarticular histiocytic sarcoma in dogs.
Manor EK; Craig LE; Sun X; Cannon CM
Vet Comp Oncol; 2018 Mar; 16(1):E83-E88. PubMed ID: 28836371
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
Cannon C; Borgatti A; Henson M; Husbands B
J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
7. Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology study.
Marconato L; Sabattini S; Buchholz J; Polton G; Finotello R; Martano M; Willman M; Massari F; Agnoli C; Gedon J; Cancedda S; Campigli M; Rohrer Bley C
Vet Comp Oncol; 2020 Dec; 18(4):778-786. PubMed ID: 32396662
[TBL] [Abstract][Full Text] [Related]
8. Primary pulmonary histiocytic sarcoma in dogs: A retrospective analysis of 37 cases (2000-2015).
Marlowe KW; Robat CS; Clarke DM; Taylor A; Touret M; Husbands BD; Vail DM
Vet Comp Oncol; 2018 Dec; 16(4):658-663. PubMed ID: 30246460
[TBL] [Abstract][Full Text] [Related]
9. Peri-articular histiocytic sarcoma and previous joint disease in Bernese Mountain Dogs.
van Kuijk L; van Ginkel K; de Vos JP; Brearley MJ; Butinar J; Gielen I; van Garderen E; Chiers K; Verhoeven PS
J Vet Intern Med; 2013; 27(2):293-9. PubMed ID: 23458888
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
13. Outcome after repair of a sarcoma-related pathologic fracture in dogs: a Veterinary Society of Surgical Oncology Retrospective Study.
Boston SE; Bacon NJ; Culp WT; Bhandal J; Bruce C; Cavanaugh RP; Hamilton MH; Lincoln JD; Liptak JM; Scharvogel S
Vet Surg; 2011 Jun; 40(4):431-7. PubMed ID: 21418255
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas.
Moore AS; Taylor DP; Reppas G; Frimberger AE
Aust Vet J; 2017 Jan; 95(1-2):37-40. PubMed ID: 28124419
[TBL] [Abstract][Full Text] [Related]
15. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006).
Abbo AH; Lucroy MD
J Am Vet Med Assoc; 2007 Dec; 231(12):1836-42. PubMed ID: 18081522
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
Mason SL; Finotello R; Blackwood L
Vet Comp Oncol; 2018 Mar; 16(1):E30-E37. PubMed ID: 28621004
[TBL] [Abstract][Full Text] [Related]
17. What is your diagnosis? Histiocytic sarcoma.
Coleman KD; Lurie DM; Blaik MA; Demuth G; Kirkby K
J Am Vet Med Assoc; 2008 Jun; 232(12):1801-2. PubMed ID: 18598147
[No Abstract] [Full Text] [Related]
18. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).
Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ
J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
[TBL] [Abstract][Full Text] [Related]
20. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
